Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-κB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function

被引:36
作者
Lee, SB [1 ]
Schorey, JS [1 ]
机构
[1] Univ Notre Dame, Dept Biol Sci, Ctr Trop Dis Res & Training, Notre Dame, IN 46556 USA
关键词
D O I
10.1128/IAI.73.10.6499-6507.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies have shown that primary murine macrophages infected with Mycobacterium avium produced lower levels of tumor necrosis factor alpha (TNF-alpha) and inducible nitric oxide synthase 2 (NOS2) compared to cells infected with nonpathogenic Mycobacterium smegmatis. TNF-alpha and NOS2 levels correlated with and were dependent on the activation of mitogen-activated protein kinases (MAPKs) p38 and extracellular signal-regulated kinase 1/2 (ERK1/2). To define the macrophage transcriptional responses dependent on ERK1/2 activation following a mycobacterial infection, we used RAW 264.7 cells transfected with a TNF-alpha or NOS2 promoter vector. We determined that macrophages infected with M. avium compared to M. smegmatis showed diminished TNF-alpha and NOS2 promoter activity. A more pronounced difference in promoter activity was observed when only the consensus ETS and NF-kappa B binding sites were used as promoters. Mutational analysis of the ETS and NF-kappa B binding sites present on the TNF-alpha and NOS2 promoters, respectively, showed that these sites were essential for a functional promoter. Moreover, the Ets/Elk but not the NF-kappa B transcriptional response was dependent on ERK1/2. This correlated with the requirement for ERK1/2 in TNF-alpha but not NOS2 promoter activity. Our data indicate that the increased Ets/Elk and NF-kappa B promoter activities associated with M. smegmatis-infected macrophages are responsible, at least in part, for the increased TNF-alpha and NOS2 production observed in these infected cells and that ERK1/2 is required for Ets/Elk activity and full TNF-alpha production.
引用
收藏
页码:6499 / 6507
页数:9
相关论文
共 32 条
[1]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[2]   Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300 [J].
Barthel, R ;
Tsytsykova, AV ;
Barczak, AK ;
Tsai, EY ;
Dascher, CC ;
Brenner, MB ;
Goldfeld, AE .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (02) :526-533
[3]  
BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[4]   Role of complement in Mycobacterium avium pathogenesis:: In vivo and in vitro analyses of the host response to infection in the absence of complement component C3 [J].
Bohlson, SS ;
Strasser, JA ;
Bower, JJ ;
Schorey, JS .
INFECTION AND IMMUNITY, 2001, 69 (12) :7729-7735
[5]   Induction of inducible nitric oxide synthase-NO• by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways [J].
Chan, ED ;
Morris, KR ;
Belisle, JT ;
Hill, P ;
Remigio, LK ;
Brennan, PJ ;
Riches, DWH .
INFECTION AND IMMUNITY, 2001, 69 (04) :2001-2010
[6]  
DIASKA M, 1999, J IMMUNOL, V162, P6171
[7]   Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter [J].
Falvo, JV ;
Uglialoro, AM ;
Brinkman, BMN ;
Merika, M ;
Parekh, BS ;
Tsai, EY ;
King, HC ;
Morielli, AD ;
Peralta, EG ;
Maniatis, T ;
Thanos, D ;
Goldfeld, AE .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (06) :2239-2247
[8]   An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide [J].
Gao, JJ ;
Morrison, DC ;
Parmely, TJ ;
Russell, SW ;
Murphy, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :1226-1230
[9]  
Holland S M, 1996, Semin Respir Infect, V11, P217
[10]   THE MYCOBACTERIUM-AVIUM COMPLEX [J].
INDERLIED, CB ;
KEMPER, CA ;
BERMUDEZ, LEM .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (03) :266-310